Breakthroughs in Muscular Dystrophy is Three Weeks Away

Register to join us in Chicago or online. - October 28, 2024

Join ASGCT and the Muscular Dystrophy Association on November 19-20, at The Westin Michigan Avenue Chicago or online, for an unparalleled opportunity to explore the latest advancements in gene and cell therapies for muscular dystrophy.

This 1.5-day event Nov. 19-20 will bring together leading researchers and clinicians from the neuromuscular disease community to explore cutting-edge gene and cell therapies and technologies for muscular dystrophy. 

Program Highlights

This comprehensive conference features world-renowned speakers and covers critical topics in muscular dystrophy research, including:

  • Keynote on Genetic Therapies for Muscular Dystrophies: Cloning the Duchenne Gene - An Origin Story - Dr. Louis Kunkel (Children's Hospital Boston)

  • Keynote on Clinical Aspects of Gene Therapies for Muscular Dystrophies - Challenges and Opportunities - Dr. Carsten Bönnemann (NINDS/NIH)

  • Non-Viral and Viral Delivery Methods

  • Monitoring AAV Delivery

  • Gene Editing Techniques

  • RNA Targeted Therapies

  • Panel Discussion on the Future of Genetic Therapies for Muscular Dystrophies

Additional features include oral abstract sessions, a poster reception, and ample networking opportunities.

View the full program     Register now!